Inhibitor Development against p7 Channel in Hepatitis C Virus

Hepatitis C Virus (HCV) is the key cause of chronic and severe liver diseases. The recent direct-acting antiviral agents have shown the clinical success on HCV-related diseases, but the rapid HCV mutations of the virus highlight the sustaining necessity to develop new drugs. p7, the viroporin protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Shukun, Hu, Xiaoyou, Du, Lingyu, Zhao, Linlin, Xue, Hongjuan, Liu, Chaolun, Chou, James J., Zhong, Jin, Tong, Yimin, Wang, Shuqing, OuYang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961618/
https://www.ncbi.nlm.nih.gov/pubmed/33802584
http://dx.doi.org/10.3390/molecules26051350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961618/
https://www.ncbi.nlm.nih.gov/pubmed/33802584
http://dx.doi.org/10.3390/molecules26051350

Ejemplares similares